Evidence map›Paper›PMID 35473752›Full record

ArticleJournal of experimental & clinical cancer research : CR2022

HIF1α-SP1 interaction disrupts the circ-0001875/miR-31-5p/SP1 regulatory loop under a hypoxic microenvironment and promotes non-small cell lung cancer progression.

Dong Wu, Tingting Chen, Xuanna Zhao, Dan Huang, Jiawei Huang, Yujie Huang, Qiu Huang, Zhu Liang, Chunyuan Chen, Min Chen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Hypoxia-induced circ_0017521 enhances glycolysis and promotes NSCLC progression via upregulating the PFKFB3/PI3K-AKT pathway.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Dong Wu *Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.ORCID http://orcid.org/0000-0002-2842-1144
Tingting Chen *Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Xuanna ZhaoDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Dan HuangDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Jiawei HuangDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Yujie HuangDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Qiu HuangDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Zhu LiangDepartment of Cardiothoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524000, China.
Chunyuan ChenDepartment of Cardiothoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524000, China.
Min ChenDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Dongming LiDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. gdyhx1111@163.com.
Bin WuDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. wubin621011@126.com.
Lixia LiCancer Hospital, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524000, China. lisalady@126.com.
Guangdong Medical College · CN

Funding

Affiliated Hospital of Guangdong Medical University "Clinical Medicine+" CnTech Co-operation Project CLP2021B001Affiliated Hospital of Guangdong Medical University "Clinical Medicine+" CnTech Co-operation Project CLP2021B017Discipline Construction Project of Guangdong Medical University 4SG21231GThe Doctoral Start-up Project of Affiliated Hospital of Guangdong Medical University BK201605The Project of Zhanjiang City 2018A01025The Project of Zhanjiang City 2020A01016The Project of Zhanjiang City 2021A05052
6 · The paper itself

Abstract

backgroundCircular RNAs (circRNAs) play an important role in the progression of non-small cell lung cancer (NSCLC), especially under tumor hypoxia. However, the precise functions and underlying mechanisms of dysregulated circRNAs in NSCLC are largely unknown.

methodsHigh-throughput RNA sequencing was performed to identify significantly expressed circRNAs in NSCLC tissues. The functions of circ-0001875 in NSCLC cells were investigated in vitro and in vivo. The regulatory relationships of circ-0001875, miR-31-5p and SP1 were examined by dual luciferase reporter assays and rescue experiments. The signal pathway of epithelial-to-mesenchymal transition and the formation of filopodia were analyzed by western blot and immunofluorescence staining. The binding of SP1 to Alu elements was evaluated by RNA immunoprecipitation, and the HIF1α and SP1 interaction was detected by co-immunoprecipitation.

resultsWe identified the novel Has_circ_0001875 as a significantly upregulated circRNA in NSCLC tissues and cell lines. circ-0001875 promoted the proliferation and metastasis of NSCLC both in vitro and in vivo, and induced NSCLC cells to extend filopodia. Mechanistically, circ-0001875 sponged miR-31-5p to regulate SP1, influencing epithelial-to-mesenchymal transition via the TGFβ/Smad2 signal pathway. SP1 negatively regulated circ-0001875 formation through an AluSq-dependent feedback loop, which was disrupted by competitive binding of HIF1α to SP1 under hypoxia condition. The circ-0001875/miR-31-5p/SP1 axis was associated with the clinical features and prognosis of NSCLC patients.

conclusionsOur results revealed that the circ-0001875/miR-31-5p/SP1 axis and the complex regulatory loops influence NSCLC progression. These findings provide new insights into the regulation of circRNA formation under tumor hypoxia.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsMicroRNAsCell ProliferationHumansHypoxiaRNA, CircularSp1 Transcription FactorTumor MicroenvironmentMicroRNAsMIRN31 microRNA, humanRNA, CircularSP1 protein, humanSp1 Transcription FactorEMTHas-circ-0001875HypoxiamiR-31-5pNon-small cell lung cancerRegulatory loopSP1

Identifiers

PMID35473752
PMCPMC9044860
OpenAlexW4224935938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.